499770-85-3

Basic information

• Product Name: 6-(BROMOMETHYL)-1,3-BENZOTHIAZOLE,97%
• Synonyms: 6-(BROMOMETHYL)-1,3-BENZOTHIAZOLE,97%;6-(Bromomethyl)-1,3-benzothiazole;6-(BroMoMethyl)benzo[d]thiazole
• CAS NO: 499770-85-3
• Molecular Formula: C8H6BrNS
• Molecular Weight: 228.10894
• Mol File: 499770-85-3.mol

Chemical Properties

• Melting Point: 100.3℃
• Appearance: /
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 6-(BROMOMETHYL)-1,3-BENZOTHIAZOLE,97%(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(BROMOMETHYL)-1,3-BENZOTHIAZOLE,97%(499770-85-3)
• EPA Substance Registry System: 6-(BROMOMETHYL)-1,3-BENZOTHIAZOLE,97%(499770-85-3)

Safety Data

• Hazard Codes: C:Corrosive
• Statements: R22:Harmful if swallowed.; R34:Causes burns.
• Safety Statements: S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S36/37/39:Wear suitabl
• Hazardous Substances Data: 499770-85-3(Hazardous Substances Data)

Upstream product

• 19989-66-3 (1,3-benzothiazol-6-yl)methanol 

Downstream Products

• 877142-68-2 C₉H₉NOS 

Relevant articles and documents

MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).

Heterocyclic antiviral compounds

Compounds having the formula I wherein A, m and R1 are herein defined are Hepatitis C virus polymerase inhibitors. Also disclosed are compositions and methods for treating diseases mediated by HCV and for inhibiting hepatitis replication. Also disclosed are processes for making the compounds and synthetic intermediates used in the process

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.